AnGes Competitors and Similar CompaniesClear all
AnGes's competitors and similar companies include Lexicon Pharmaceuticals and Ionis Pharmaceuticals.
 AnGes AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine. |  Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology. |  Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics. | |
Founding Date | Founding Date 1999 | Founding Date 1995 | Founding Date 1989 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Ibaraki, JP HQ Fujisawa, JP Ibaraki, JP Kawasaki, JP Minato City, JP Bethesda, US | Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more | |
Employees | Employees 5562% decrease | Employees 20216% increase | Employees 1,40231% increase |
Valuation ($) | Valuation ($) 78.3 m | Valuation ($) 737.4 m | Valuation ($) 6.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) ¥874.1m (FY, 2025) | Revenue (est.) $49.8m (FY, 2025) | Revenue (est.) $943.7m (FY, 2025) |
Cost of goods | Cost of goods ¥499.9m (FY, 2025) | Cost of goods $274k (FY, 2025) | Cost of goods $15.9m (FY, 2025) |
Gross profit | Gross profit ¥374.2m (FY, 2025) | Gross profit $49.5m (FY, 2025) | Gross profit $927.8m (FY, 2025) |
Net income | Net income (¥5.1b) (FY, 2025) | Net income ($50.3m) (FY, 2025) | Net income ($381.4m) (FY, 2025) |
Operating ⚠ | |||
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products 1 (FY, 2016) | Phase I Trials Products 1 (FY, 2023) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 2 (FY, 2016) | Phase III Trials Products 17 (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Lexicon Pharmaceuticals
HQ
The Woodlands, US
Employees
202↑ 16% increase
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
View companyIonis Pharmaceuticals
HQ
Carlsbad, US
Employees
1,402↑ 31% increase
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
View company